<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
72769-181-03
</NDCCode>
<PackageDescription>
3 VIAL, GLASS in 1 CARTON (72769-181-03) / 20 mL in 1 VIAL, GLASS (72769-181-01)
</PackageDescription>
<NDC11Code>
72769-0181-03
</NDC11Code>
<ProductNDC>
72769-181
</ProductNDC>
<ProductTypeName>
HUMAN PRESCRIPTION DRUG
</ProductTypeName>
<ProprietaryName>
Rapivab
</ProprietaryName>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Peramivir
</NonProprietaryName>
<DosageFormName>
SOLUTION
</DosageFormName>
<RouteName>
INTRAVENOUS
</RouteName>
<StartMarketingDate>
20141220
</StartMarketingDate>
<EndMarketingDate/>
<MarketingCategoryName>
NDA
</MarketingCategoryName>
<ApplicationNumber>
NDA206426
</ApplicationNumber>
<LabelerName>
BioCryst Pharmaceuticals, Inc.
</LabelerName>
<SubstanceName>
PERAMIVIR
</SubstanceName>
<StrengthNumber>
600
</StrengthNumber>
<StrengthUnit>
mg/60mL
</StrengthUnit>
<Pharm_Classes/>
<DEASchedule/>
<Status>
Active
</Status>
<LastUpdate>
2024-06-22
</LastUpdate>
<PackageNdcExcludeFlag>
N
</PackageNdcExcludeFlag>
<ProductNdcExcludeFlag>
N
</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough>
20261231
</ListingRecordCertifiedThrough>
<StartMarketingDatePackage>
20141220
</StartMarketingDatePackage>
<EndMarketingDatePackage/>
<SamplePackage>
N
</SamplePackage>
</NDC>